Related references
Note: Only part of the references are listed.Structural Basis of Pharmacological Chaperoning for Human β-Galactosidase
Hironori Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling
Na Liu et al.
PLOS ONE (2013)
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
Jan Novak et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Histone Deacetylase (HDAC) Activity Is Critical for Embryonic Kidney Gene Expression, Growth, and Differentiation
Shaowei Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Protein Acetylation in the Cardiorenal Axis The Promise of Histone Deacetylase Inhibitors
Erik W. Bush et al.
CIRCULATION RESEARCH (2010)
Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
Maoyin Pang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
IgA nephropathy at two score and one
Rosanna Coppo et al.
KIDNEY INTERNATIONAL (2010)
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
KIDNEY INTERNATIONAL (2010)
Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10
Sufyan G. Sayyed et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury
Takeshi Marumo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Effects of histone deacetylase inhibitors on rat mesangial cells
Ilya Freidkin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-β1-induced renal injury
Hyunjin Noh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy
Konstantinos Giannakakis et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy
Jia-Xiang Ding et al.
CLINICAL IMMUNOLOGY (2007)
Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules
Y.-H. Gao et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy
LX Xu et al.
KIDNEY INTERNATIONAL (2005)
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
RA Blaheta et al.
MEDICINAL RESEARCH REVIEWS (2005)
Role of macromolecular IgA in IgA nephropathy
PJM van der Boog et al.
KIDNEY INTERNATIONAL (2005)
Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis - Association with dephosphorylation of STAT3
Y Kalechman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101
Y Kalechman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system
KN Lai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor
K Rombouts et al.
JOURNAL OF HEPATOLOGY (2002)
Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-β1-induced fibrogenesis in skin fibroblasts
K Rombouts et al.
EXPERIMENTAL CELL RESEARCH (2002)
Smad7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad2 activation
JH Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis
Y Kanamaru et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
